Parry-Romberg Syndrome and Temporal Lobe Refractory Epilepsy: Case Report

Journal of Epilepsy Research
A Velandia-MartínezA Martínez-Perez

Abstract

The Parry-Romberg syndrome (PRS), also known as hemifacial atrophy, is a rare neurocutaneous disease with the prevalence of 1/700,000 cases. It is more common in women than men, with an early onset of disease usually within the first two decades of life. Even though the etiology of PRS is unknown, it is thought to be a multifactorial disease that involves hereditary, posttraumatic, autoimmune, infectious, and neoplastic factors. There are a variety of systemic manifestations described in PRS including neurological conditions that range from intractable headache to refractory epilepsy. The manifestations must be identified in a timely manner to ensure an early therapeutic intervention, considering that an appropriate approach during the initial phase might halt the disease progression and markedly improve the quality of life in these patients. This article is aimed to describe the case of a 23 years old female with left hemifacial atrophy and dermatologic, dental, and neurologic compromise, associated with refractory temporal lobe epilepsy evidenced in neuroimaging and electrodiagnostic testings.

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Journal of the Neurological Sciences
Gurjit ChokarRosaria Buccoliero
Journal of Dermatological Case Reports
Elizabeth LazaridouDemetris Ioannides
Avicenna Journal of Medicine
Nader A Al-AizariBassel Tarakji
No to hattatsu. Brain and development
M UmemotoH Takeshi
Pediatric Dermatology
Kamaldeep Sandhu, Sanjeev Handa
© 2022 Meta ULC. All rights reserved